Discovery
23andMe identifies genetic predictors of GLP-1 weight loss and side effects in Nature study
23andMe researchers report genetic predictors of GLP-1 receptor agonist weight loss and side effects in Nature
Methodist Hospital Research Institute receives USD 2.47m NIAID grant for gasdermin C research
The Methodist Hospital Research Institute in Houston has received a four-year R01 award totaling USD 2,469,932 from the National Institute of Allergy and...
Weill Cornell Medicine receives USD 3.25m NIH award for AAV gene therapy Alzheimer's trial
Weill Cornell Medicine has received a USD 3.25 million UG3 award from the National Institute on Aging to advance an AAV-mediated gene therapy into Phase I...
Johns Hopkins receives USD 2.86m NIH award for DROIDp brain organoid platform
Johns Hopkins University has received a UM1 cooperative agreement award of USD 2,856,513 from the National Center for Advancing Translational Sciences for...
UPenn picks up USD 1.1m NHLBI grant for CRISPR base-editing CVD program
The University of Pennsylvania's Kiran Musunuru has received an R35 award from the National Heart, Lung, and Blood Institute totaling USD 1,137,435 in...
Stanford University receives USD 3.09m NCATS award for AI-driven cardiac organoid platform development
Stanford University has received a USD 3.09 million UM1 award from the National Center for Advancing Translational Sciences to develop COIN, a...
Landmark Bio picks up USD 18.3m ARPA-H award for extracellular vesicle manufacturing platform
Watertown, Mass.-based Landmark Bio has secured an ARPA-H award of up to USD 18.3 million to develop a continuous manufacturing platform for extracellular...
Lancet: Chia Tai's benmelstobart and anlotinib combo outperforms pembrolizumab in lung cancer trial
Researchers across 79 centres in China report that benmelstobart anlotinib lung cancer combination therapy produced statistically significant improvements...
Sinopia Biosciences receives NCI grant to apply LEADS metabolomics platform to oncology drug discovery
Sinopia Biosciences, a privately held biotechnology company headquartered at JLABS San Diego, announced in March 2026 that it has been awarded a research...
Researchers report first in vivo CAR-T cell generation in multiple myeloma patients using ESO-T01 vector
Investigators in China report that a single intravenous infusion of ESO-T01, a nanobody-directed lentiviral vector, generated functional anti-BCMA CAR-T...
University of Toronto researchers show reengineered long noncoding RNAs reduce inflammation in macrophages and mice
Researchers at the University of Toronto and The Hospital for Sick Children (SickKids) in Toronto, Canada, report that naturally occurring long noncoding...
Novomedix wins $2.98 million NCI contract to advance oral drug for pediatric solid tumors
Novomedix, a San Diego-based for-profit company, has received a $2.98 million SBIR Phase II contract from the National Cancer Institute to advance a...
The AllSci Brief
Free, systematic R&D and deal news. Daily.